HRP20041079B1 - Nova sol perindoprila i farmaceutski pripravci koji je sadrže - Google Patents

Nova sol perindoprila i farmaceutski pripravci koji je sadrže

Info

Publication number
HRP20041079B1
HRP20041079B1 HRP20041079AA HRP20041079A HRP20041079B1 HR P20041079 B1 HRP20041079 B1 HR P20041079B1 HR P20041079A A HRP20041079A A HR P20041079AA HR P20041079 A HRP20041079 A HR P20041079A HR P20041079 B1 HRP20041079 B1 HR P20041079B1
Authority
HR
Croatia
Prior art keywords
pharmaceutical compositions
compositions containing
containing same
novel
perindopril salt
Prior art date
Application number
HRP20041079AA
Other languages
English (en)
Inventor
Gérard Damien
François Lefoulon
Bernard Marchand
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8871521&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20041079(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20041079A2 publication Critical patent/HRP20041079A2/xx
Publication of HRP20041079B1 publication Critical patent/HRP20041079B1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Predmetni se izum odnosi na novu sol perindoprila i farmaceutske pripravke koji je sadrže.
HRP20041079AA 2002-04-18 2004-11-17 Nova sol perindoprila i farmaceutski pripravci koji je sadrže HRP20041079B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0204847A FR2838648B1 (fr) 2002-04-18 2002-04-18 Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
PCT/FR2003/000507 WO2003087050A2 (fr) 2002-04-18 2003-02-17 Sel de perindopril et les compositions pharmaceutiques qui le contiennent

Publications (2)

Publication Number Publication Date
HRP20041079A2 HRP20041079A2 (en) 2004-12-31
HRP20041079B1 true HRP20041079B1 (hr) 2013-04-30

Family

ID=8871521

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20041079AA HRP20041079B1 (hr) 2002-04-18 2004-11-17 Nova sol perindoprila i farmaceutski pripravci koji je sadrže

Country Status (38)

Country Link
US (1) US6696481B2 (hr)
EP (1) EP1354873B1 (hr)
JP (1) JP3737488B2 (hr)
KR (1) KR100542468B1 (hr)
CN (1) CN1211365C (hr)
AP (1) AP1787A (hr)
AR (1) AR039428A1 (hr)
AT (1) ATE271036T1 (hr)
AU (2) AU2003222921A1 (hr)
BR (1) BR0300709A (hr)
CA (1) CA2423825C (hr)
CR (1) CR7576A (hr)
DE (1) DE60300011T2 (hr)
DK (1) DK1354873T3 (hr)
EA (1) EA005676B1 (hr)
EC (1) ECSP045441A (hr)
ES (1) ES2224092T3 (hr)
FR (1) FR2838648B1 (hr)
GE (1) GEP20074211B (hr)
HK (1) HK1057367A1 (hr)
HR (1) HRP20041079B1 (hr)
IL (1) IL164424A (hr)
IS (1) IS2842B (hr)
MA (1) MA27115A1 (hr)
ME (1) ME00454B (hr)
MX (1) MXPA03002346A (hr)
NO (1) NO324323B1 (hr)
NZ (1) NZ524478A (hr)
OA (1) OA12806A (hr)
PL (1) PL359321A1 (hr)
PT (1) PT1354873E (hr)
RS (1) RS51694B (hr)
SI (1) SI1354873T1 (hr)
TN (1) TNSN04206A1 (hr)
TR (1) TR200401793T4 (hr)
UA (1) UA79463C2 (hr)
WO (1) WO2003087050A2 (hr)
ZA (1) ZA200301395B (hr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
DK1729739T3 (en) * 2004-03-29 2016-10-31 Servier Lab PROCESS FOR THE PREPARATION OF A solid pharmaceutical composition.
SI21800A (sl) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
ATE409036T1 (de) * 2005-01-06 2008-10-15 Ipca Lab Ltd Verfahren zur synthese von (2s,3as,7as)-1-(s)- alanyl-octahydro-1h-2-carbonsäurederivaten und verwendung in der synthese von perindopril
ES2329923T3 (es) * 2005-03-14 2009-12-02 Les Laboratoires Servier Procedimiento mejorado para la purificacion de perindopril.
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2897866B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
SI22542A (sl) * 2007-06-04 2008-12-31 Diagen D.O.O. Stabilna formulacija amorfnih soli perindoprila, postopek za njeno pripravo v industrijskem merilu in njena uporaba za zdravljenje hipertenzije
WO2009157018A2 (en) 2008-06-24 2009-12-30 Matrix Laboratories Ltd Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof
AU2009212902A1 (en) * 2008-09-03 2010-03-18 Apotex Pharmachem Inc. Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
CN101766598A (zh) * 2008-12-31 2010-07-07 东英（江苏）药业有限公司 含有培哚普利的药物组合物
GB0910692D0 (en) * 2009-06-20 2009-08-05 Teva Pharma Compound
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
FR2985512B1 (fr) 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
FR2985511B1 (fr) 2012-01-05 2014-01-03 Servier Lab Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN103172696B (zh) * 2012-12-19 2014-12-17 宁波美诺华药业股份有限公司 一种γ晶型的培哚普利精氨酸盐的制备方法
FR3040303B1 (fr) * 2015-08-27 2019-04-05 Les Laboratoires Servier Suivi Par Sabine Goudeau-Wenger Composition pharmaceutique comprenant un inhibiteur de la hmg-coa reductase et un inhibiteur eca
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules
SI26268A (sl) 2021-11-18 2023-05-31 Zupet Rok Postopek za pripravo hidratirane oblike perindopril l-arginina

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001087835A1 (fr) * 2000-07-06 2001-11-22 Les Laboratoires Servier FORME CRISTALLINE α DU SEL DE TERT-BUTYLAMINE DU PERINDOPRIL

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001087835A1 (fr) * 2000-07-06 2001-11-22 Les Laboratoires Servier FORME CRISTALLINE α DU SEL DE TERT-BUTYLAMINE DU PERINDOPRIL

Also Published As

Publication number Publication date
CR7576A (es) 2008-08-21
MXPA03002346A (es) 2005-08-26
IS7516A (is) 2004-10-27
IS2842B (is) 2013-08-15
ME00454B (me) 2011-10-10
PL359321A1 (en) 2003-10-20
KR100542468B1 (ko) 2006-01-11
NZ524478A (en) 2004-05-28
AU2003200700B2 (en) 2005-01-20
AP1787A (en) 2007-10-04
EP1354873B1 (fr) 2004-07-14
CN1451656A (zh) 2003-10-29
NO20030849D0 (no) 2003-02-24
TR200401793T4 (tr) 2004-08-23
TNSN04206A1 (en) 2007-03-12
IL164424A (en) 2010-12-30
AU2003222921A1 (en) 2003-10-27
HRP20041079A2 (en) 2004-12-31
US6696481B2 (en) 2004-02-24
IL164424A0 (en) 2005-12-18
GEP20074211B (en) 2007-10-10
DE60300011D1 (de) 2004-08-19
HK1057367A1 (en) 2004-04-02
FR2838648A1 (fr) 2003-10-24
JP3737488B2 (ja) 2006-01-18
AU2003200700A1 (en) 2003-11-06
EA200300334A1 (ru) 2003-12-25
FR2838648B1 (fr) 2004-05-21
US20030199568A1 (en) 2003-10-23
SI1354873T1 (en) 2004-12-31
EP1354873A1 (fr) 2003-10-22
RS90904A (en) 2007-02-05
CN1211365C (zh) 2005-07-20
DE60300011T2 (de) 2005-03-17
DK1354873T3 (da) 2004-11-01
UA79463C2 (en) 2007-06-25
EA005676B1 (ru) 2005-04-28
JP2003321493A (ja) 2003-11-11
AR039428A1 (es) 2005-02-16
ZA200301395B (en) 2003-09-02
PT1354873E (pt) 2004-10-29
AU2003222921A8 (en) 2003-10-27
AU2003200700C1 (en) 2015-04-23
CA2423825C (fr) 2006-02-21
AP2004003154A0 (en) 2004-12-31
NO324323B1 (no) 2007-09-24
BR0300709A (pt) 2004-09-08
WO2003087050A2 (fr) 2003-10-23
OA12806A (en) 2006-07-11
ATE271036T1 (de) 2004-07-15
ECSP045441A (es) 2005-03-10
CA2423825A1 (fr) 2003-10-18
ES2224092T3 (es) 2005-03-01
KR20030082902A (ko) 2003-10-23
NO20030849L (no) 2003-10-20
RS51694B (en) 2011-10-31
MA27115A1 (fr) 2004-12-20
WO2003087050A3 (fr) 2004-03-25

Similar Documents

Publication Publication Date Title
HRP20041079B1 (hr) Nova sol perindoprila i farmaceutski pripravci koji je sadrže
ATE385781T1 (de) Montelukast-granulatformulierung
UY29007A1 (es) Derivados de 2-carbamida-4-feniltiazol, su preparacinn, y su aplicacinn en terapcutica
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
DE60329237D1 (de) Kristalline form von linezolid
DE60325153D1 (de) Gekapselte Riechstoffzusammensetzungen
DE60312277D1 (de) Gekapselte Riechstoffzusammensetzungen
EE200100487A (et) Uudsed ühendid ja kompositsioonid proteaasiinhibiitoritena
DE60332321D1 (de) Ultrafeine zusammensetzungen von formoterol
SE0301653D0 (sv) Novel compounds
DK1458377T3 (da) Farmaceutiske sammensætninger indeholdende tegaserod
UA87335C2 (en) Gel composition of 4-hydroxytamoxifen
DE50301661D1 (de) Darreichungsform von Ibuprofen-Natrium
SE9901077D0 (sv) Novel use
NO20044305L (no) Stabile farmasoytiske blandinger inneholdende faktor VIII
NO20063293L (no) Farmasoytiske forbindelser
FR2834893B1 (fr) Composition pharmaceutique orodispersible de perindopril
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
GB0221169D0 (en) Crystal
FR2835431B1 (fr) COMPOSITION COSMETIQUE CONTENANT UNE Nx,Ng-DIACYLARGININE
EA200600172A1 (ru) Фармацевтическая композиция для интраназального введения пирибедила
MY135184A (en) New salt of perindopril and pharmaceutical compositions containing it
ATE460421T1 (de) Phosphinsäurederivate
HN2002000113A (es) Sales tartrato de 5, 8, 14 - triazatetraciclo [10.3.1.02,11.04,9] hexadeca - 2 (11), 3,5,7,9 - pentaeno y composiciones farmaceuticas de las mismas.
ITMI20020926A1 (it) Composizioni farmaceutiche riepitelizzanti

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20190128

Year of fee payment: 17

ODRP Renewal fee for the maintenance of a patent

Payment date: 20200128

Year of fee payment: 18

ODRP Renewal fee for the maintenance of a patent

Payment date: 20210104

Year of fee payment: 19

ODRP Renewal fee for the maintenance of a patent

Payment date: 20220111

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20230217